01
Ampoules
Liquid sterile preparations in ampoule formats.
Sterile & injectable manufacturing
Complex sterile dosage forms. Built for scale.
From ampoules and vials to pre-filled syringes, lyophilized products, drops and infusions, Akums supports diverse sterile and injectable formats through specialized manufacturing units.
767 MnAnnual sterile capacity*
MultipleSpecialized manufacturing units
20+ YearsCDMO experience
The dosage-form story
When sterile delivery demands more than one manufacturing pathway.
Akums’ sterile and injectable portfolio spans multiple delivery formats and specialized production environments. The focus is not simply on making an injectable — it is on matching the formulation and delivery format to the right manufacturing pathway.
Sterile dosage forms
One manufacturing network. Multiple sterile formats.
Our published capabilities cover a broad range of sterile preparations and injectable formats.
02
Vials
Liquid, dry-powder and lyophilized vial pathways.
03
Pre-filled syringes
Pre-filled sterile delivery format for injectable applications.
04
Large & Small Volume Parenterals
SVP and LVP formats, including LVP in 100 mL.
05
Lyophilized & Dry-Powder Injectables
Lyophilized vials and dry-powder injection pathways, including DPI.
06
Eye, Ear & Nasal Drops
Specialized sterile ophthalmic and nasal preparations.
07
FFS & Three-Piece Packs
Form-fill-seal and three-piece sterile packaging formats.
08
Respules & UNIMS
Respules and single-unit UNIMS packs for specialized sterile delivery.
Manufacturing network
Multiple units. More manufacturing pathways.
For B2B partners, manufacturing resilience matters. Akums has sterile/injectable capabilities distributed across specialized units, reducing dependence on a single manufacturing location and creating more options for production planning and portfolio growth.
UNIT 01 · HARIDWAR
Plant-III
Ampoules, vials, three-piece, LVP, SVP, PFS, DPI and nasal/eye drops.
UNIT 02 · HARIDWAR
Plant-IV
Hormonal injectables in vials and ampoules, alongside other hormonal dosage forms.
UNIT 03 · HARIDWAR
Plant-VII
Injectables I: ampoules, three-piece vials, DPI & FFS. Injectables L: DPI & LVP.
UNIT 04 · KOTDWAR
Plant-X
Dedicated injectable manufacturing including beta-lactam dry powder injections.
Why the network matters
Designed for manufacturing resilience.
Multiple specialized units can give partners greater flexibility as requirements change across development, capacity and markets.
Less dependence on one site
Multiple manufacturing pathways can reduce concentration around a single manufacturing location.
Format-specific pathways
Different sterile formats can be routed toward units aligned with their published dosage-form capabilities.
Capacity planning flexibility
A distributed network creates additional options as portfolios scale or manufacturing requirements evolve.
From development to commercial supply
Built around the product, not just the plant.
For sterile and injectable projects, the manufacturing pathway should follow the dosage form, formulation requirements, regulatory pathway and commercial need.
01
Formulation & development
Define the sterile dosage form and product requirements.
02
Technology transfer & scale-up
Move from development into an appropriate commercial manufacturing pathway.
03
Manufacturing & quality
Production under specialized sterile manufacturing environments and quality systems.
04
Commercial supply
Support market requirements with scalable manufacturing capacity.
Let’s build the right manufacturing pathway
Have a sterile or injectable formulation in mind?
Tell us your dosage form, product requirements and market. Our team can help identify the appropriate manufacturing pathway.
enquiry@akums.net →*Sterile capacity figure and dosage-form/unit mapping are based on Akums’ published manufacturing information. Plant-XII is proposed and is therefore not included in the current-unit network above.